SPRY (ARS Pharmaceuticals) Kacepetan wutah bathi saben saham ing taun lumaku
Geopolitical instability may disrupt component supplies and complicate global drug certification. However, ARS Pharmaceuticals (SPRY) relies on a unique nasal spray, the demand for which guarantees a stable cash flow. Production risks are mitigated by outsourcing packaging to external partners and establishing reserves. The proportional growth in EPS compared to last year demonstrates profitability dynamics, where the current mark equals -4.00.
Rincian analitis lan laporan data perusahaan ARS Pharmaceuticals (SPRY)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- rincian utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi ARS Pharmaceuticals|SPRY - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal ars-pharma.com|SPRY - Gunggung utang perusahaan|Rasio utang marang aset resik ARS Corp|SPRY - Utang jangka dawa perusahaan|Kewajiban jangka cendhak ARS Pharmaceuticals|Rasio jangkoan perantara ars-pharma.com
- indikator pendapatan resik lan kelipatan nilai:
SPRY - Bathi resik|Proyeksi bathi mangsa ngarep ARS Pharmaceuticals|SPRY - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi ARS Corp|SPRY - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ARS Corp|SPRY - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) ARS Pharmaceuticals|SPRY - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan ars-pharma.com|SPRY - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep ARS Pharmaceuticals
Ringkesan analisis perusahaan:ARS Pharmaceuticals Inc (SPRY)
This indicator measures the year-over-year dynamics of net earnings per share, allowing for an assessment of business scaling efficiency and the accuracy of management's financial plan execution. By analyzing the EPS comparison with the previous year, an investor can correlate profit growth rates with the commercialization of needle-free delivery systems, specifically the Neffy nasal spray, which determines the investment attractiveness of ARS Pharmaceuticals (SPRY).
Pesaing utama
Haleon PLC - Tambahing bathi saben saham ing taun lumaku|KVUE (Kenvue Corp) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Verona Pharma Inc. VRNA|Wutah bathi saben saham ing taun lumaku Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku AMRX (Amneal)|Wutah bathi ing taun lumaku Perrigo Company PLC PRGO|ALVO - Wutah bathi saben saham ing taun lumaku|Tambahing bathi saben saham ing taun lumaku LQDA (Liquidia Inc.)|Galapagos NV (GLPG) - Wutah bathi saben saham ing taun lumaku|ANIP - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben saham ing taun iki MNKD|AMPH: Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Pacira (PCRX)|TBPH: Dinamika bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku AQST (Aquestive Therapeutics)|Tambahing bathi saben saham ing taun lumaku SCPH|Tectonic - Wutah bathi ing taun lumaku|TNXP - Wutah bathi ing taun lumaku|sxtchina.com (SXTC) - Wutah bathi saben saham ing taun lumaku|Eupraxia Pharmaceuticals Inc. - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku BioHarvest Sciences|Wutah bathi resik saben saham ing taun iki invizyne.com (EXOZ)|Wutah bathi ing taun lumaku ORMP|Wutah bathi ing taun lumaku enterabio.com (ENTX)|Wutah bathi ing taun lumaku HYFT (MindWalk)|ABVC - Wutah bathi resik saben saham ing taun iki|Cumberland Pharmaceuticals - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku quantumbiopharma.com|FGEN (FibroGen) - Wutah bathi resik saben saham ing taun iki|Telomir Pharmaceuticals Inc (TELO) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki RANI|SNYR (Synergy CHC Corporation) - Wutah bathi resik saben siji saham kanggo taun lumaku|Wutah bathi ing taun lumaku RLYB|Prakiraan wutah bathi resik saben saham ing taun iki lexariabioscience.com|Wutah bathi ing taun lumaku PULM (Pulmatrix)|PTHL - Wutah bathi resik saben saham ing taun iki|Aptorum - Wutah bathi ing taun lumaku|LYRA - Wutah bathi ing taun lumaku|Impact BioMedical (IBO) - Wutah bathi saben saham ing taun lumaku|TNFA (TNF Pharmaceuticals, Inc.) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku cbdMD Inc.|PainReform Ltd (PRFX) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku Altamira Therapeutics (CYTO)|Prakiraan wutah bathi resik saben saham ing taun iki Lipella Pharma|Wutah bathi saben saham ing taun lumaku OptiNose, Inc. OPTN|PIRS (pieris.com) - Dinamika bathi saben saham ing taun lumaku|PROC - Wutah bathi saben saham ing taun lumaku|Tambahing bathi saben saham ing taun lumaku PTPI (Petros Pharmaceuticals Inc)|QLI (Qilian International Holding Group Limited) - Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku ACELYRIN Inc. (SLRN)|Wutah bathi saben saham ing taun lumaku TFF Pharmaceuticals
